Viatris Inc. and Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced May 19th, that Abevmy® (bevacizumab) is now available in …
Read more on pharmprom.net
Pharmaceutical Industry in Russia flipped this story into PharmProm.Net•46d
